Search

everythinglearnresearchcommunity

for

Search:↓

Most patients improved in both atopic dermatitis and alopecia areata with certain treatments, but some had worsened symptoms, suggesting personalized care is needed.

Targeting pyroptosis may offer new treatments for alopecia areata, but more research is needed.

Understanding sex and gender differences can improve personalized dermatology care.

Sonic Hedgehog helps keep skin and airway barriers healthy and reduces inflammation.

Blood metabolites significantly influence alopecia areata risk.

BMD-1141 effectively regrows hair in alopecia areata with less frequent dosing than current treatments.

Compound glycyrrhizin with conventional treatments is effective and safe for hair regrowth in alopecia areata.

No single ideal JAK inhibitor for alopecia areata has been determined; JAK3 inhibitors may be promising with fewer side effects.

Granzyme B is important in autoimmune skin diseases and could be a new treatment target.

Lifestyle changes and environmental strategies can help address declining testosterone levels.

Japanese patients with alopecia areata often have a higher BMI and consume more vitamin C, fruit, and retinol, which may affect their condition's development or severity.

Recognizing scalp symptoms in PRP is crucial for proper diagnosis and treatment.

Higher miR-34a levels and the A variant of the MIR-34A gene are linked to increased risk and severity of alopecia areata.

Understanding how acne develops in different diseases could lead to new treatments.

Alopecia areata needs more recognition and better treatment access in Latin America to improve patient care and outcomes.

A gene variant increases the risk of a type of hair loss by affecting hair protein production.

New treatments for hair loss show promise with advanced therapies and better targeting.

New understanding and treatments for hair loss are improving, but more research is needed.

Medicinal plants show promise for skin disorders but need more research for safe clinical use.

New therapies are being developed that target integrin pathways to treat various diseases.

Chronic skin diseases and metabolic syndrome are linked by shared inflammation pathways.

Wigs help improve self-esteem and quality of life for people with hair loss from alopecia areata.

JAK inhibitors show promise for treating skin disorders like alopecia, eczema, and psoriasis.

Dupilumab and ustekinumab are promising treatments for alopecia areata, showing significant hair regrowth.

New treatments are needed for non-scarring alopecia due to current limitations.

MJ04, a new compound, effectively promotes hair growth and is a potential topical treatment for hair loss.

Dupilumab effectively treats various inflammatory skin diseases beyond its initial use for atopic dermatitis.

Using mesenchymal stem cells or their exosomes is safe for COVID-19 patients and helps improve lung healing and oxygen levels.

Adipose mesenchymal stem cells are best for skincare because they reduce inflammation and are safe and effective.

Different types of cell death affect skin health and inflammation, and understanding them could improve treatments for skin diseases.